Joseph A. Tyndall - 09 Dec 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Reporting relationship: Director
Issuer ticker: AXGN
Reported as of: 09 Dec 2025
Net transaction value: -$558,548
SEC form: 4
Accepted by SEC: 10 Dec 2025, 17:20:46 UTC
Prior SEC filing: 20 Jun 2025
Next SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Marc Began as attorney-in-fact for Joseph A. Tyndall

Key filing fact

Joseph A. Tyndall filed Form 4 for Axogen, Inc. (AXGN) on 10 Dec 2025.

Key facts

This page summarizes Joseph A. Tyndall's Form 4 filing for Axogen, Inc. (AXGN).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Dec 2025, 17:20.

Change

Previous filing in this sequence was filed on 20 Jun 2025.
Current net transaction value: -$558,548.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001955281 Primary reporting owner

TYNDALL JOSEPH A.

Relationship: Director
Address: C/O AXOGEN, INC. 13631 PROGRESS BLVD.,, SUITE 400, ALACHUA
Signature: /s/ Marc Began as attorney-in-fact for Joseph A. Tyndall
Signature date: 10 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXGN transaction

Common Stock

Options Exercise

Transaction value: $100,306
Shares: +14,248
Change %
Price: $7.04
Shares after: 14,248
Date: 09 Dec 2025
Ownership: Direct

AXGN transaction

Common Stock

Options Exercise

Transaction value: $118,917
Shares: +10,860
Change %: +76%
Price: $10.95
Shares after: 25,108
Date: 09 Dec 2025
Ownership: Direct

AXGN transaction

Common Stock

Sale

Transaction value: $441,360
Shares: -14,248
Change %: -57%
Price: $30.98
Shares after: 10,860
Date: 09 Dec 2025
Ownership: Direct
Footnotes: F1

AXGN transaction

Common Stock

Sale

Transaction value: $336,410
Shares: -10,860
Change %: -100%
Price: $30.98
Shares after: 0
Date: 09 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXGN transaction Derivative

Employee Stock Option (right to purchase)

Options Exercise

Transaction value: $0
Shares: -14,248
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 09 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,248
Exercise price: $7.04
Footnotes: F2

AXGN transaction Derivative

Stock Option (right to purchase)

Options Exercise

Transaction value: $0
Shares: -10,860
Change %: -25%
Price: $0.000000
Shares after: 32,311
Date: 09 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,860
Exercise price: $10.95
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.485 to $31.305 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

Non-qualified stock option portion of the 2024 annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant vested on June 6, 2025, the one-year anniversary of the grant date.

Footnote F3

Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 13, 2023.